JBF Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

JBF Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.6M	Sell	92,000 -13,000	-12%	-$1.76M	1.91%	9
2026 Q1	$13.4M	Hold	105,000	–	–	1.98%	7
2025 Q4	$12.8M	Buy	105,000 +90,000	+600%	+$10.3M	1.85%	8
2025 Q3	$1.5M	Buy	+15,000	New	+$1.35M	0.21%	30
2024 Q4	–	Sell	-59,800	Closed	-$5.91M	–	93
2024 Q3	$5.91M	Hold	59,800	–	–	0.88%	20
2024 Q2	$5.54M	Hold	59,800	–	–	0.86%	16
2024 Q1	$5.67M	Buy	+59,800	New	+$5.55M	0.93%	15
2022 Q2	–	Sell	-86,435	Closed	-$7.77M	–	85
2022 Q1	$7.77M	Hold	86,435	–	–	1.62%	13
2021 Q4	$9.68M	Buy	86,435 +17,560	+25%	+$2.12M	1.82%	11
2021 Q3	$8.66M	Buy	+68,875	New	+$8.87M	1.86%	9

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

JBF Capital's XBI Position: Q2 2026 in Review

JBF Capital reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 12% in Q2 2026, selling an estimated $1.76M and leaving 92,000 shares worth $14.6M. The position accounts for 1.91% of the portfolio, ranked #9.

JBF Capital first reported a position in XBI in Q3 2021 and has held it in 10 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

JBF Capital held 92,000 shares of State Street SPDR S&P Biotech ETF worth $14.6M as of Q2 2026.
JBF Capital sold 13,000 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.76M.
State Street SPDR S&P Biotech ETF made up 1.91% of JBF Capital's portfolio in Q2 2026, its #9 holding.
JBF Capital first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and has held it in 10 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on JBF Capital's 13F filing for Q2 2026, filed 13 Aug 2026.